Navigation Links
Amarin Secures Global Intellectual Property Rights for Lipid Programs
Date:3/3/2008

LONDON, March 3 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRN) today announced that it has signed an exclusive license with Scarista Limited ("Scarista") for the development and commercialization rights to a broad intellectual property portfolio in the field of lipid science. This intellectual property portfolio is complementary to Amarin's existing lipid-based development programs including AMR101 and its targeted lipid transport technology. The transaction consideration comprises an upfront fee to Scarista of $0.5 million and royalties upon commercialization.

In 2004, Amarin licensed rights to this portfolio, covering applications in diseases of the central nervous system for North America, the EU and Japan. This new license provides Amarin with rights to all remaining therapeutic areas and all territories worldwide.

Thomas Lynch, Amarin's Chairman and Chief Executive Officer, commented "This is an important strategic step for Amarin that strengthens our position to establish global partnerships with our lipid programs. In addition, access to broader potential applications will allow us to take advantage of new opportunities outside the CNS field, such as cardiovascular disease."

Declan Doogan M.D., Amarin's Head of Research and Development, added "The field of lipid science has matured significantly in the past two decades, and now contributes a range of important prescription drug treatments for various medical conditions associated with the vascular system, including cardiovascular disease. In addition, real medical benefits have been identified with new development stage candidates based on lipid science, achieving recognition in prestigious scientific publications. Amarin enjoys a prominent pla
'/>"/>

SOURCE Amarin Corporation Plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amarin Appoints Dr. William Mason as Lead Independent Director
2. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
3. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
4. Amarin Signs Agreement to Acquire Ester Neurosciences
5. Amarin Corporation to Present at Acumen BioFin Rodman & Renshaw Ninth Annual Healthcare Conference
6. Amarin Announces Initiation of Cardiovascular Development Strategy
7. Amarin to Present at 4th Annual Bio Investor Forum
8. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
9. Ranier Technology Secures GBP8m Funding for its Cadisc Replacement Spinal Discs
10. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition
11. Taligen Therapeutics Secures Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 BCC Research ( http://www.bccresearch.com ) ... Enzymes in Industrial Applications , the global market for ... billion by 2018, registering a five-year compound annual growth ... be recorded in the detergent enzyme segment with a ... technology has influenced almost every sector of industrial activity, ...
(Date:7/30/2014)... July 30, 2014  Dyadic International, Inc. ("Dyadic") ... patented and proprietary technologies are used to discover, ... for the bioenergy, bio-based chemical, biopharmaceutical and industrial ... "Tom" Dubinski as Vice President and Chief Financial ... financial and information technology operations for Dyadic and ...
(Date:7/30/2014)... July 30, 2014  RXi Pharmaceuticals Corporation ... company focused on discovering, developing and commercializing ... using RNA-targeted technologies, today announced that their ... for the reduction of recurrence of hypertrophic ... been initiated. Logo - ...
(Date:7/30/2014)... 2014 Adding to their already extensive ... special – Buy 2 of any Weighing Boats ... benefit lab technicians looking for durable and reliable weighing ... for multiple applications including weighing liquids, solid, or granulated ... including diamond-shaped, hexagonal, square, aluminum weighing, and standard boats. ...
Breaking Biology Technology:Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Thomas Dubinski joins Dyadic as Chief Financial Officer 2Thomas Dubinski joins Dyadic as Chief Financial Officer 3Thomas Dubinski joins Dyadic as Chief Financial Officer 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 2RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 3RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 4RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic Scars 5Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2
... (OTC.BB: FPMI), a biopharmaceutical company developing the ... of its official stock ticker symbol from CEWM to ... previously announced FluoroPharma Inc. merger with CEWM. ... biopharmaceutical company engaged in the discovery and development of ...
... N.C., June 3, 2011 Recent biopharmaceutical product launches ... the cardiovascular therapeutic area. Faced with a continually evolving ... the biggest role in the current launch environment. ... explores the pivotal success factors and failure points facing ...
... 3, 2011 LifeVantage Corporation (OTCBB: ... science-based therapy for the reduction of oxidative stress ... that a new peer-reviewed review article involving Protandim® ... Research .   (Logo:   http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO ...
Cached Biology Technology:FluoroPharma Medical Announces Stock Ticker Symbol Change 2Creating a Road Map for Successful Cardiovascular New Product Launch 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 3LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 4LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 5
(Date:7/29/2014)... world of science, researchers sometimes need to get ... did just that to study the impacts of ... coral reef ecosystems at two remote locations in ... animal tracking and computer simulation, McCauley, an assistant ... Marine Biology, and his colleagues sought to understand ...
(Date:7/29/2014)... plays a major role in locomotion. Swimming microorganisms, such ... inertial forces compared to the viscous forces exerted by ... a major challenge. Now, scientists have found that the ... opposite to that induced by a viscoelastic fluid. These ... by Franois Nadal from the Alternative Energies and Atomic ...
(Date:7/29/2014)... on the remote UK overseas territory of Ascension Island, ... undergoing something of a renaissance. , Writing in the ... University of Exeter and Ascension Island Government Conservation Department ... the remote South Atlantic outpost has increased by more ... 1970s. As many as 24,000 nests are now estimated ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Optimum inertial self-propulsion design for snowman-like nanorobot 2Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2
... Efforts on the Growing Issue of Identity Management , ... WASHINGTON , July ... today announced that it has expanded its mission to focus on the ... biometric and other technologies play an increasingly important role, has been deemed ...
... Having discovered a dramatic increase of an easy-to-detect enzyme ... prediabetes, Johns Hopkins scientists say the discovery could lead to ... the disease, before symptoms or complications occur and in time ... 22 in Diabetes , show the enzyme O-GlcNAcase is ...
... 8, 2010 A new system for the controlled ... team of University of Rhode Island chemical engineers using ... by non-invasive electromagnetic fields. The discovery by URI ... Yanjing Chen was published in the June issue of ...
Cached Biology News:The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 2The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 3Hopkins team discovers sweet way to detect prediabetes 2Researchers develop drug delivery system using nanoparticles triggered by electromagnetic field 2
MMP-20 Immunogen: Activated recombinant human MMP-2 Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rabbit anti-T-box 6...
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
...
Biology Products: